This announcement is a separate document:
海普瑞：深圳市海普瑞药业集团股份有限公司2020年面向合格投资者公开发行公司债券（疫情防控债）2021年定期受托管理事务报告
Hepry: Shenzhen Haipuri Pharmaceutical Group Co., Ltd. publicly issued corporate bonds to qualified investors in 2020 (epidemic prevention and control bonds) 2021 regular fiduciary management affairs report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.